FluidAI Medical announces an acquisition deal with Emmetros Limited

FluidAI Medical, a medical expertise firm that develops novel {hardware}, software program, and synthetic intelligence (AI) options, in the present day introduced an acquisition deal with SparxConnect developer Emmetros Limited, a number one firm within the affected person engagement area. The acquisition enhances Stream Inara, an AI-powered affected person training and engagement platform inside FluidAI’s product portfolio that extends care past the hospital. This is FluidAI’s second acquisition deal after Medsix. Strategic acquisitions stay a core a part of FluidAI’s development technique, strengthening its place in present markets and increasing its footprint with established merchandise and applied sciences.

Stream Inara is a part of FluidAI’s Recovery Intelligence and Surgical Excellence (RISE) Program, a high quality enchancment program designed to enhance surgical care and allow Enhanced Recovery After Surgery (ERAS) protocols. RISE spans the whole surgical journey and contains Stream Care, an AI-assisted Surgical Expert Suite; the FDA-cleared Origin monitoring gadget; and Stream Inara for post-discharge affected person training and engagement at house. The RISE program allows the adoption of tailor-made, data-driven options that align with every establishment’s scientific targets.

Stream Inara extends surgical care past the hospital, serving as a digital administration instrument earlier than surgical procedure and after sufferers return house. The platform screens sufferers after discharge, collects patient-reported outcomes, and gives customized training, steady engagement, and 24/7 assist to assist sufferers adhere to care plans and get well safely. Integrating Stream Inara into FluidAI’s RISE Program is designed to assist earlier discharge. As a consequence, sufferers can get well at house, hospitals can enhance affected person throughput and optimize mattress use, and clinicians can stay assured figuring out their sufferers keep related all through restoration.

“I couldn’t be extra happy about this acquisition by FluidAI, which represents the absolute best subsequent chapter for our expertise and our mission,” mentioned Emmetros CEO and Co-Founder Mary Pat Hinton. “Their staff shares our deep dedication to bettering surgical affected person outcomes and care experiences via innovation, and their experience in real-time steady monitoring actually is the proper complement to our extremely customizable and extensible affected person engagement and collaboration platform.”

“Emmetros has at all times been devoted to patient-centric care. Focused on options that empower sufferers and care suppliers, they’ve set the usual for a way we will interact and talk with sufferers,” mentioned Youssef Helwa, CEO of FluidAI. “This acquisition helps FluidAI’s mission in redefining the usual of surgical care to enhance affected person outcomes throughout restoration for safer early discharge after common and gastrointestinal surgical procedure.”

The publish FluidAI Medical announces an acquisition deal with Emmetros Limited first appeared on AI-Tech Park.